Mental Health Research for Innovation Centre (M-RIC)
MRIC is a key demonstrator site for the UK’ Mental Health Mission that is building new capacity for research in the UK’s largest mental health and community services NHS Trust, Mersey Care, and developing new UK capability in digital mental health embedded in health system wide dataflows.
Find out more about MRIC.
Liverpool City Region Civic Data Cooperative (CDC)
CDC is the UK’s first civic cooperative of data rightsholders, controllers and innovators, working together to mobilise data securely into trustworthy AIs that improve health, social wellbeing and inclusive economic growth.
Find out more about CDC.
Data-into-Action programme
A population health management system of programmable prevention, precision and payment (System-P) fed by the Combined Intelligence for Population Health Action (CIPHA) infrastructure that links analytics with care workflows, and feeding research via the Northwest NHS Subnational Secure Data Environment (SDE) and its allied Data-Action Accelerator initiative including training in data science and digital innovation.
DynAIRx
Research into Artificial Intelligence (AI) to help optimise prescriptions for patients with multiple long-term conditions on multiple medicines, avoiding medication harms and improving outcomes including quality of life.
Find out more about DynAIRx.
SysteMatic
Design and engineering of data-driven integration of services for people living with multiple long-term conditions, where poor coordination of services impairs outcome, especially for the most disadvantaged in society.
Find out more about SysteMatic.
Children Growing Up in Liverpool (C-GULL)
The C-GULL study aims to understand how inequalities affect health from early life, involving 10,000 first born babies with biological samples from the individual, their mother and partner, plus study of their ‘digital twin’s journey’ with data linked from multiple public service contacts and research measurements.
Find out more about C-GULL.
The Pandemic Institute FluVue Project
A real-world evidence study of vaccine uptake and outcomes in partnership with sponsor Seqirus.
Find out more about The Pandemic Institute.
CAMO-Net
CHIL provides CAMO-Net with a UK data science and real-world digital innovation site for its multidisciplinary global collaboration working to address the impact of antimicrobial resistance on human health. AMR-X is building and testing components of an antimicrobial learning system in Cheshire and Merseyside.
Find out more about CAMO-Net.
PHIRST LiLaC
An action-research network providing public health research support for front-line public health teams to answer questions with CHIL’s data science support.
Find out more about PHIRST LiLaC.
Health Protection Research Unit for Gastrointestinal Infections (HPRU GI)
Data science and digital innovation input to the HPRU GI, including social determinants, geo-data-science methodology and health policy research.
Find out more about HPRU GI.
Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI)
Data science, digital and civic innovation support to the HPRU EZI, including intelligence frameworks for pandemic testing building on the mass-testing work of CHIL’s team in COVID-19.
Find out more about HPRU EZI.
ARISTOTELES and AFFIRMO
Learning system informatics approaches from the CHIL team applied to continuous improvement of atrial fibrillation care, including new clinical prediction methods leveraging machine learning techniques.
NIHR Liverpool Health Determinants Research Centre
Building capacity to study the wider determinants of health with and for Liverpool city residents, including state-of-the art civic data science and governance.
Understanding and Preventing Cardiovascular diseases in people taking AntiPsychotic medications: a data-driven mixed methods study (PreCAP)
The PreCAP programme, with national data and stakeholder engagement, aims to establish evidence and recommendations for improved cardiovascular disease prevention and management in individuals prescribed antipsychotic medications. The results will tailor care pathways for patients on antipsychotics to reduce their risk of cardiovascular diseases, which will be tested in the NHS.
Back to: Civic Health Innovation Labs (CHIL)